https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/77Publicationshttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/211Characterisation of Eosinophilic Bronchiectasis: A European Multicohort StudyFri, 28 Jan 2022 17:39:41 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/211https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/207Heterogeneity of treatment response in bronchiectasis clinical trialsFri, 28 Jan 2022 17:21:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/207https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/206Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendationsFri, 28 Jan 2022 17:15:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/206https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/205Relationship between Symptoms, Exacerbations, and Treatment Response in BronchiectasisFri, 28 Jan 2022 17:08:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/205https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/204A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trialFri, 28 Jan 2022 17:05:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/204https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/202British Thoracic Society Guideline for bronchiectasis in adultsFri, 28 Jan 2022 16:53:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/202https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/200Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics studyFri, 28 Jan 2022 16:43:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/200https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/198BronchUK: protocol for an observational cohort study and biobank in bronchiectasisFri, 28 Jan 2022 13:53:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/198https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/183European Respiratory Society guidelines for the management of adult bronchiectasisMon, 11 Sep 2017 08:58:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/183https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/175EMBARC/BRR definitions working group. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchFri, 28 Jul 2017 09:49:04 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/175https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/169Heightened Autoantibody Immune Response to Citrullinated Calreticulin in Bronchiectasis: Implications for Rheymatoid ArthritisFri, 28 Jul 2017 09:26:50 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/169https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/165Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lungWed, 14 Jun 2017 10:30:02 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/165https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/164Bronchiectasis and Aspergillus: How are they linked?Wed, 14 Jun 2017 10:28:00 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/164https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/163Applying the Transtheoretical Model to Physical Activity Behavior in Individuals With Non-Cystic Fibrosis Bronchiectasis.Wed, 14 Jun 2017 10:26:14 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/163https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/162Critical care admission trends and outcomes in individuals with bronchiectasis in the UKWed, 14 Jun 2017 10:18:39 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/162https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/161Bronchiectasis: how to be an orphan with many parents?Wed, 14 Jun 2017 10:16:27 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/161https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/160The EMBARC European Bronchiectasis Registry: protocol for an international observational study.Wed, 14 Jun 2017 10:14:06 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/160https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/152The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort studyWed, 14 Jun 2017 10:00:03 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/152https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/149Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research CollaborationFri, 29 Jul 2016 10:18:11 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/149https://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/147Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasisFri, 29 Jul 2016 10:00:24 GMThttps://bronchiectasisuk.hicservices.dundee.ac.uk:443/Contents/Item/Display/147